España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Revvity
RVTY
NYSE
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$108.15
-1.65
-1.50%
At Close: -
$108.15
0
0.00%
After Hours: Jul 19, 4:00 PM EDT
15 minutes delayed
Get Report
Comment
The dividend Ex-Date was 2 days ago
Q2 2024 Earnings in 8 days from now on Mon Jul 29th, before the market open
Revvity (RVTY) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Revvity (NYSE:RVTY) Stock
Revvity Stock (NYSE: RVTY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 08, 2024
Leerink Partners Initiates Coverage On Revvit...
Benzinga Newsdesk
Wednesday, July 03, 2024
Reasons to Retain Revvity Stock in Your Portfolio Now
Zacks
Friday, June 28, 2024
Barclays Maintains Equal-Weight on Revvity, L...
Benzinga Newsdesk
Tuesday, April 30, 2024
Baird Maintains Outperform on Revvity, Raises...
Benzinga Newsdesk
4 Analysts Have This To Say About Revvity
Benzinga Insights
TD Cowen Maintains Buy on Revvity, Raises Pri...
Benzinga Newsdesk
Monday, April 29, 2024
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
Piero Cingari
Revvity shares are trading higher after the c...
Benzinga Newsdesk
Revvity Reaffirms Its 2024 Adjusted EPS Guida...
Benzinga Newsdesk
Revvity Revises 2024 Revenue Forecast To $2.7...
Benzinga Newsdesk
Revvity Q1 2024 Adj EPS $0.98 Beats $0.93 Est...
Benzinga Newsdesk
Wednesday, April 24, 2024
Revvity Announced The Launch Of The Auto-pure...
Benzinga Newsdesk
Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Monday, April 15, 2024
Revvity To Launch Signals Synergy, Software S...
Benzinga Newsdesk
Tuesday, April 02, 2024
Massachusetts Superior Court Has Granted A Pr...
Benzinga Newsdesk
Wednesday, March 20, 2024
Revvity Reaffirms 2024 Full Year Guidance Of ...
Benzinga Newsdesk
Revvity Files Complaint Against Cloud Softwar...
Benzinga Newsdesk
Monday, March 18, 2024
Revvity's Software And Informatics Division, ...
Benzinga Newsdesk
Monday, February 12, 2024
Revvity Signals Software Unveils Signals Clinical Solution To Accelerate Critical Clinical Trial Insights And Data-Driven Decisions
Happy Mohamed
Friday, February 02, 2024
Stifel Maintains Hold on Revvity, Raises Pric...
Benzinga Newsdesk
Keybanc Maintains Overweight on Revvity, Rais...
Benzinga Newsdesk
Raymond James Maintains Outperform on Revvity...
Benzinga Newsdesk
Thursday, February 01, 2024
Revvity Forecasts 2024 Revenue Of $2.79B-$2.8...
Benzinga Newsdesk
Revvity Q4 Adjusted EPS $1.25 Beats $1.16 Est...
Benzinga Newsdesk
Earnings Scheduled For February 1, 2024
Benzinga Insights
Wednesday, January 31, 2024
Earnings Preview For Revvity
Benzinga Insights
Thursday, January 25, 2024
The Latest Analyst Ratings For Revvity
Benzinga Insights
Barclays Maintains Equal-Weight on Revvity, R...
Benzinga Newsdesk
Tuesday, January 16, 2024
UBS Downgrades Revvity to Neutral, Raises Pri...
Benzinga Newsdesk
Tuesday, January 09, 2024
Revvity shares are trading higher after the c...
Benzinga Newsdesk
Revvity Reports Preliminary Revenue For The F...
Benzinga Newsdesk
Thursday, January 04, 2024
Peeling Back The Layers: Exploring Revvity Through Analyst Insights
Benzinga Insights
Evercore ISI Group Upgrades Revvity to Outper...
Benzinga Newsdesk
Tuesday, December 19, 2023
Wells Fargo Initiates Coverage On Revvity wit...
Benzinga Newsdesk
Wednesday, December 13, 2023
7 Analysts Have This to Say About Revvity
Benzinga Insights
Wolfe Research Initiates Coverage On Revvity ...
Benzinga Newsdesk
Tuesday, October 31, 2023
Raymond James Maintains Outperform on Revvity...
Benzinga Newsdesk
Goldman Sachs Maintains Buy on Revvity, Lower...
Benzinga Newsdesk
Keybanc Maintains Overweight on Revvity, Lowe...
Benzinga Newsdesk
Monday, October 30, 2023
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Why Biotechnology Company Revvity's Shares Diving Today
Lekha Gupta
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Revvity shares are trading lower after the co...
Benzinga Newsdesk
Earnings Scheduled For October 30, 2023
Benzinga Insights
Revvity Expects FY23 Adjusted EPS Of $4.53-$4...
Benzinga Newsdesk
Revvity Expects FY23 Revenue Of $2.72B-$2.74B...
Benzinga Newsdesk
Revvity Q3 Adjusted EPS $1.18 Misses $1.19 Es...
Benzinga Newsdesk
Friday, October 27, 2023
Earnings Outlook For Revvity
Benzinga Insights
Wednesday, October 18, 2023
Raymond James Maintains Outperform on Revvity...
Benzinga Newsdesk
Tuesday, October 17, 2023
What 6 Analyst Ratings Have To Say About Revvity
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch